Text this: Tumor marker analyses from the phase III, placebo-controlled, FASTACT-2 study of intercalated erlotinib with gemcitabine/platinum in the first-line treatment of advanced non-small-cell lung cancer

__    __    ______     _____     ___      ______  
\ \\ / //  /_   _//   / ___//   / _ \\   /_____// 
 \ \/ //    -| ||-    \___ \\  | / \ ||  `____ `  
  \  //     _| ||_    /    //  | \_/ ||  /___//   
   \//     /_____//  /____//    \___//   `__ `    
    `      `-----`  `-----`     `---`    /_//     
                                         `-`